These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

483 related articles for article (PubMed ID: 29972798)

  • 1. Targeting Breast Cancer Stem Cell State Equilibrium through Modulation of Redox Signaling.
    Luo M; Shang L; Brooks MD; Jiagge E; Zhu Y; Buschhaus JM; Conley S; Fath MA; Davis A; Gheordunescu E; Wang Y; Harouaka R; Lozier A; Triner D; McDermott S; Merajver SD; Luker GD; Spitz DR; Wicha MS
    Cell Metab; 2018 Jul; 28(1):69-86.e6. PubMed ID: 29972798
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Keap1-Nrf2 Pathway Regulates ALDH and Contributes to Radioresistance in Breast Cancer Stem Cells.
    Kamble D; Mahajan M; Dhat R; Sitasawad S
    Cells; 2021 Jan; 10(1):. PubMed ID: 33419140
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting Cancer Stem Cell Redox Metabolism to Enhance Therapy Responses.
    Luo M; Wicha MS
    Semin Radiat Oncol; 2019 Jan; 29(1):42-54. PubMed ID: 30573183
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting of the Glutathione, Thioredoxin, and Nrf2 Antioxidant Systems in Head and Neck Cancer.
    Roh JL; Jang H; Kim EH; Shin D
    Antioxid Redox Signal; 2017 Jul; 27(2):106-114. PubMed ID: 27733046
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of the Nrf2-regulated antioxidant cell response inhibits HEMA-induced oxidative stress and supports cell viability.
    Gallorini M; Petzel C; Bolay C; Hiller KA; Cataldi A; Buchalla W; Krifka S; Schweikl H
    Biomaterials; 2015 Jul; 56():114-28. PubMed ID: 25934285
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ROS-independent ER stress-mediated NRF2 activation promotes warburg effect to maintain stemness-associated properties of cancer-initiating cells.
    Chang CW; Chen YS; Tsay YG; Han CL; Chen YJ; Yang CC; Hung KF; Lin CH; Huang TY; Kao SY; Lee TC; Lo JF
    Cell Death Dis; 2018 Feb; 9(2):194. PubMed ID: 29416012
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ZMYND8 protects breast cancer stem cells against oxidative stress and ferroptosis through activation of NRF2.
    Luo M; Bao L; Xue Y; Zhu M; Kumar A; Xing C; Wang JE; Wang Y; Luo W
    J Clin Invest; 2024 Jan; 134(6):. PubMed ID: 38488001
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dual pharmacological inhibition of glutathione and thioredoxin systems synergizes to kill colorectal carcinoma stem cells.
    Tanaka G; Inoue K; Shimizu T; Akimoto K; Kubota K
    Cancer Med; 2016 Sep; 5(9):2544-57. PubMed ID: 27485632
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhancement of Radiation Response in Breast Cancer Stem Cells by Inhibition of Thioredoxin- and Glutathione-Dependent Metabolism.
    Rodman SN; Spence JM; Ronnfeldt TJ; Zhu Y; Solst SR; O'Neill RA; Allen BG; Guan X; Spitz DR; Fath MA
    Radiat Res; 2016 Oct; 186(4):385-395. PubMed ID: 27643875
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nuclear Factor Erythroid-Derived 2-Like 2-Induced Reductive Stress Favors Self-Renewal of Breast Cancer Stem-Like Cells
    Kim DH; Jang JH; Kwon OS; Cha HJ; Youn HJ; Chun KS; Surh YJ
    Antioxid Redox Signal; 2020 Jun; 32(18):1313-1329. PubMed ID: 31672029
    [No Abstract]   [Full Text] [Related]  

  • 11. Nrf2 deficiency induces oxidative stress and promotes RANKL-induced osteoclast differentiation.
    Hyeon S; Lee H; Yang Y; Jeong W
    Free Radic Biol Med; 2013 Dec; 65():789-799. PubMed ID: 23954472
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Redox signaling by glutathione peroxidase 2 links vascular modulation to metabolic plasticity of breast cancer.
    Ren Z; Liang H; Galbo PM; Dharmaratne M; Kulkarni AS; Fard AT; Aoun ML; Martinez-Lopez N; Suyama K; Benard O; Zheng W; Liu Y; Albanese J; Zheng D; Mar JC; Singh R; Prystowsky MB; Norton L; Hazan RB
    Proc Natl Acad Sci U S A; 2022 Feb; 119(8):. PubMed ID: 35193955
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypoxia promotes the phenotypic change of aldehyde dehydrogenase activity of breast cancer stem cells.
    Shiraishi A; Tachi K; Essid N; Tsuboi I; Nagano M; Kato T; Yamashita T; Bando H; Hara H; Ohneda O
    Cancer Sci; 2017 Mar; 108(3):362-372. PubMed ID: 28012234
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ursolic acid inhibits the proliferation of triple‑negative breast cancer stem‑like cells through NRF2‑mediated ferroptosis.
    Yang X; Liang B; Zhang L; Zhang M; Ma M; Qing L; Yang H; Huang G; Zhao J
    Oncol Rep; 2024 Jul; 52(1):. PubMed ID: 38847277
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oxidative stress induces senescence in breast cancer stem cells.
    Zhong G; Qin S; Townsend D; Schulte BA; Tew KD; Wang GY
    Biochem Biophys Res Commun; 2019 Jul; 514(4):1204-1209. PubMed ID: 31109646
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined inhibition of glycolysis, the pentose cycle, and thioredoxin metabolism selectively increases cytotoxicity and oxidative stress in human breast and prostate cancer.
    Li L; Fath MA; Scarbrough PM; Watson WH; Spitz DR
    Redox Biol; 2015; 4():127-35. PubMed ID: 25560241
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Downregulation of CXCR7 inhibits proliferative capacity and stem cell-like properties in breast cancer stem cells.
    Tang X; Li X; Li Z; Liu Y; Yao L; Song S; Yang H; Li C
    Tumour Biol; 2016 Oct; 37(10):13425-13433. PubMed ID: 27460092
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selective mode of action of plumbagin through BRCA1 deficient breast cancer stem cells.
    Somasundaram V; Hemalatha SK; Pal K; Sinha S; Nair AS; Mukhopadhyay D; Srinivas P
    BMC Cancer; 2016 May; 16():336. PubMed ID: 27229859
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The PRAK-NRF2 axis promotes the differentiation of Th17 cells by mediating the redox homeostasis and glycolysis.
    Zhao Z; Wang Y; Gao Y; Ju Y; Zhao Y; Wu Z; Gao S; Zhang B; Pang X; Zhang Y; Wang W
    Proc Natl Acad Sci U S A; 2023 May; 120(19):e2212613120. PubMed ID: 37126714
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diallyl Disulfide Inhibits Breast Cancer Stem Cell Progression and Glucose Metabolism by Targeting CD44/PKM2/AMPK Signaling.
    Xie X; Huang X; Tang H; Ye F; Yang L; Guo X; Tian Z; Xie X; Peng C; Xie X
    Curr Cancer Drug Targets; 2018; 18(6):592-599. PubMed ID: 29110616
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.